Thomas John Dietz Eiger Bio Pharmaceuticals, Inc. (EIGR) insider trading activity

Thomas John Dietz is of Eiger BioPharmaceuticals, Inc.. Currently has a direct ownership of 21,000 shares of EIGR, which is worth approximately $199,500. The most recent transaction as insider was on Dec 22, 2022, when has been sold 22,500 shares (Common Stock) at a price of $1.17 per share, resulting in proceeds of $26,325. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 21K

0% 3M change

0% 12M change

Total Value Held $199,500

Thomas John Dietz Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 22 2022	SELL Open market or private sale	$26,325 $1.17 p/Share	22,500 Reduced 51.72%	21,000 Common Stock
Mar 11 2022	BUY Grant, award, or other acquisition	-	6,000 Added 12.12%	43,500 Common Stock
Apr 09 2021	BUY Open market or private purchase	$21,225 $8.49 p/Share	2,500 Added 6.25%	37,500 Common Stock
Mar 12 2021	BUY Grant, award, or other acquisition	-	5,000 Added 12.5%	35,000 Common Stock

Also insider at

LPTX

LEAP THERAPEUTICS, INC. Healthcare

Director

PRTK

Paratek Pharmaceuticals, Inc. Healthcare

Director

TJD